Diagnosis, Management and Prevention of Acute Hemolytic Anemia in Infants, Children and Adolescents

The lake of availability of national guidelines that address acute hemolytic anemia management in recourse limited country is the main limitation to our work.

Future research recommendations for acute hemolytic anemia in children in the Egyptian context could include:

▪️ The impact of time lapses between presentation to the ER and starting transfusion on the morbidity and mortality of patients with acute hemolytic crisis.

▪️   The incident of AIHA in Egypt on the post COVID era.

Other recommendations aim to address specific challenges and characteristics of the Egyptian context, potentially leading to more effective prevention and management strategies for acute hemolytic anemia in children.

➡️Challenges

▪️ Training primary care doctor to spot patients with acute hemolysis and know how to approach such cases, recognizing patients that need urgent hospitalization or intensive care management and avoidance of any delay that may results in grave consequences.

▪️ Emphasis on avoiding empiric antibiotics description for patients with diarrhea.

▪️ Implementation of international guidelines in resource limited settings.

▪️   The optimum use of the available resources to fulfill the requirements of Egyptian population.

Strengthen the evidence base of the next update of this guideline by generating GRADE summary of finding tables, evidence profiles, and EtD frameworks

➡️Monitoring and evaluating the impact of the guideline.

The following are three performance measures or indicators for implementing this adapted CPG for acute hemolytic anemia in children:

1.     Adherence to acute hemolytic anemia Guidelines

▪️  Numerator: Number of children with acute hemolytic anemia who received treatment as per guideline recommendations.

▪️ Denominator: Total number of children diagnosed with acute hemolytic anemia.

▪️   Data Source: Hospital or clinic patient records.

2.     Duration of Hospital Stay

▪️   Numerator: Total number of hospital stay days for children with acute hemolytic anemia.

▪️  Denominator: Total number of children admitted with acute hemolytic anemia.

▪️    Data Source: Hospital admission and discharge records.

3.     Rate of Readmission

▪️   Numerator: Number of children readmitted with symptoms of acute hemolytic anemia within a certain period (e.g., 30 days) after discharge.

▪️   Denominator: Total number of children initially admitted with acute hemolytic anemia.

▪️    Data Source: Hospital readmission records.

These key performance indicators are designed to measure the effectiveness and adherence to the guidelines, the efficiency of the treatment in terms of resource utilization (hospital stay), and the success of the treatment in preventing further complications (readmissions).